Effects of ex-vivo and in-vivo treatment with probiotics on the inflammasome in dogs with chronic enteropathy

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Schmitz, Silke ^a,b   Werling, Dirk ^a   Allenspach, Karin ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; CARRIER PROTEIN; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CASP 1 GENE; CHRONIC ENTEROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS FAECALIS; ENTEROPATHY; EX VIVO STUDY; FEMALE; GENE EXPRESSION REGULATION; IL 18 GENE; IL 1BETA GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN VIVO STUDY; INNATE IMMUNITY; MALE; NLRP3 GENE; NONHUMAN; PROTEIN DIET; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; ANIMAL; BIOSYNTHESIS; ENTEROCOCCUS FAECIUM; GENE EXPRESSION; GENETICS; INTESTINE; METABOLISM; VETERINARY;

CANIS FAMILIARIS; ENTEROCOCCUS FAECIUM;

ANIMALS; CARRIER PROTEINS; CASPASE 1; DOGS; ENTEROCOCCUS FAECIUM; GENE EXPRESSION; INFLAMMASOMES; INTERLEUKIN-1BETA; INTESTINAL DISEASES; INTESTINES; LIGANDS; PROBIOTICS; TOLL-LIKE RECEPTORS;

EID: 84925711176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120779     Document Type: Article

References (38)

1. Allenspach K, Wieland B, Grone A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007; 21: 700-708. PMID: 17708389
2. Simpson KW, Jergens AE. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet Clin North Am Small Anim Pract. 2011; 41: 381-398. doi: 10.1016/j.cvsm.2011.02.003 PMID: 21486642
3. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010; 32: 379-391. doi: 10.1016/j.immuni.2010.03.003 PMID: 20303296
4. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, et al. Critical role for Cryopyrin/ Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem. 2006; 281: 36560-36568. PMID: 17008311
5. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006; 440: 233-236. PMID: 16407888
6. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006; 440: 228-232. PMID: 16407890
7. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10: 417-426. PMID: 12191486
8. Werts C, Girardin SE, Philpott DJ. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ. 2006; 13: 798-815. PMID: 16528382
9. Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA. 2009; 106: 9021-9026. doi: 10.1073/pnas.0812690106 PMID: 19439663
10. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009; 27: 229-265. doi: 10.1146/annurev.immunol.021908.132715 PMID: 19302040
11. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007; 14: 10-22. PMID: 16977329
12. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011; 243: 206-214. doi: 10.1111/j.1600-065X.2011.01044.x PMID: 21884178
13. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 1992; 37: 818-826. PMID: 1587185
14. McCabe RP, Secrist H, Botney M, Egan M, Peters MG. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol. 1993; 66: 52-58. PMID: 8440073
15. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr, Foley E, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol. 1999; 162: 6829-6835. PMID: 10352304
16. Pages F, Lazar V, Berger A, Danel C, Lebel-Binay S, Zinzindohoue F, et al. Analysis of interleukin-18, interleukin-1 converting enzyme (ICE) and interleukin-18-related cytokines in Crohn's disease lesions. Eur Cytokine Netw. 2001; 12: 97-104. PMID: 11282552
17. Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, Kosaka T, et al. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol. 2002; 37 Suppl 14: 111-116. PMID: 12572878
18. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet. 2009; 41: 71-76. doi: 10.1038/ ng.285 PMID: 19098911
19. Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol. 2011; 32: 171-179. doi: 10.1016/j.it.2011.02.002 PMID: 21388882
20. Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010; 59: 1192-1199. doi: 10.1136/gut.2009.197822 PMID: 20442201
21. Bauer C, Duewell P, Lehr HA, Endres S, Schnurr M. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis. 2012; 30 Suppl 1: 82-90. doi: 10.1159/000341681 PMID: 23075874
22. Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis. 2011; 17: 1359-1372. doi: 10.1002/ibd.21478 PMID: 20872834
23. FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Basel, Switzerland: World Health Organization. 2001.
24. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013; 62: 787-796. doi: 10.1136/gutjnl-2012-302504 PMID: 23474420
25. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes. 2011; 2: 109-114. PMID: 21637028
26. Maeda S, Ohno K, Nakamura K, Uchida K, Nakashima K, Uchida K, et al. Mucosal imbalance of interleukin- 1beta and interleukin-1 receptor antagonist in canine inflammatory bowel disease. Vet J. 2012; 194: 66-70. doi: 10.1016/j.tvjl.2012.02.026 PMID: 22483380
27. Eckhart L, Ballaun C, Uthman A, Gawlas S, Buchberger M, Fischer H, et al. Duplication of the caspase- 12 prodomain and inactivation of NLRC4/IPAF in the dog. Biochem Biophys Res Commun. 2009; 384: 226-230. doi: 10.1016/j.bbrc.2009.04.092 PMID: 19394309
28. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut. 1998; 42: 214-219. PMID: 9536946
29. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol. 1999; 163: 143-147. PMID: 10384110
30. Olson AD, Ayass M, Chensue S. Tumor necrosis factor and IL-1 beta expression in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993; 16: 241-246. PMID: 8492249
31. Daig R, Rogler G, Aschenbrenner E, Vogl D, Falk W, Gross V, et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut. 2000; 46: 350-358. PMID: 10673296
32. Waterhouse CC, Stadnyk AW. Rapid expression of IL-1beta by intestinal epithelial cells in vitro. Cell Immunol. 1999; 193: 1-8. PMID: 10202107
33. Peters IR, Helps CR, Calvert EL, Hall EJ, Day MJ. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Int Med. 2005; 19: 644-653. PMID: 16231708
34. Schmitz S, Garden OA, Werling D, Allenspach K. Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease. Vet Immunol Immunopathol. 2012; 146: 87-91. doi: 10.1016/j.vetimm.2012.01.013 PMID: 22333286
35. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: 1-11.
36. Peters IR, Peeters D, Helps CR, Day MJ. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Vet Immunol Immunopathol. 2007; 117: 55-66. PMID: 17346803
37. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55: 611-622. doi: 10.1373/clinchem.2008.112797 PMID: 19246619
38. Sauter SN, Allenspach K, Gaschen F, Grone A, Ontsouka E, Blum JW. Cytokine expression in an ex vivo culture system of duodenal samples from dogs with chronic enteropathies: modulation by probiotic bacteria. Domest Anim Endocrinol. 2005; 29: 605-622. PMID: 15941645